Diagnosis and management of neuroendocrine prostate cancer

Although most patients with prostate cancer (PC) respond to initial androgen deprivation therapy (ADT), castration-resistant disease invariably develops. Progression to treatment-emergent neuroendocrine PC (t-NEPC) represents a unique mechanism of resistance to androgen receptor (AR)-targeted therap...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Prostate 2024-04, Vol.84 (5), p.426-440
Hauptverfasser:	de Kouchkovsky, Ivan, Chan, Emily, Schloss, Charles, Poehlein, Christian, Aggarwal, Rahul
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Androgen receptors Androgens Biomarkers Cancer therapies Castration Chemotherapy Diagnosis Metastases Patients Prostate cancer Small cell lung carcinoma Therapeutic targets
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!